Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Dyne Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2023 4 Scalzo Richard William (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Sold 1,390 shares @ $12.43, valued at $17.3k
Sold 40,000 shares @ $12.89, valued at $515.6k
Sold 10,000 shares @ $12.03, valued at $120.3k
Exercised 40,000 options to buy @ $1.03, valued at $41.2k
06/12/2023 4 Brumm Joshua T (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Gifted 20,000 shares @ $0
Gifted 1,800 shares @ $0
Sold 46,811 shares @ $13.15, valued at $615.6k
Sold 14,189 shares @ $13.47, valued at $191.1k
Sold 76,582 shares @ $13.34, valued at $1M
Sold 187,748 shares @ $12.61, valued at $2.4M
Exercised 30,088 options to buy @ $1.03, valued at $31k
Exercised 76,582 options to buy @ $1.03, valued at $78.9k
Exercised 171,360 options to buy @ $1.03, valued at $176.5k
05/25/2023 4 Stehman-Breen Catherine (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 24,900 options to buy @ $13.49, valued at $335.9k
05/25/2023 4 Rhodes Jason P (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 24,900 options to buy @ $13.49, valued at $335.9k
05/25/2023 4 Lubner David Charles (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 24,900 options to buy @ $13.49, valued at $335.9k
05/25/2023 4 Kersten Dirk (10% Owner) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 24,900 options to buy @ $13.49, valued at $335.9k
05/25/2023 4 Incerti Carlo (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 24,900 options to buy @ $13.49, valued at $335.9k
05/25/2023 4 HURWITZ EDWARD (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 24,900 options to buy @ $13.49, valued at $335.9k
03/15/2023 4 Scalzo Richard William (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Sold 1,311 shares @ $13.33, valued at $17.5k
03/15/2023 4 McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Sold 1,000 shares @ $13, valued at $13k
Sold 1,209 shares @ $13.33, valued at $16.1k
03/15/2023 4 HIGH SUSANNA GATTI (COO) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Sold 1,559 shares @ $13.33, valued at $20.8k
03/15/2023 4 Farwell Wildon (Chief Medical Officer) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Sold 7,441 shares @ $13.33, valued at $99.2k
03/15/2023 4 Brumm Joshua T (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Sold 7,318 shares @ $13.33, valued at $97.5k
03/15/2023 4 Beskrovnaya Oxana (Chief Scientific Officer) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Sold 1,416 shares @ $13.33, valued at $18.9k
01/23/2023 4 McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Sold 10,000 shares @ $14.03, valued at $140.3k
Exercised 10,000 options to buy @ $0.73, valued at $7.3k
01/11/2023 4 McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Sold 30,150 shares @ $11.57, valued at $348.8k
12/14/2022 4 Rhodes Jason P (Director) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Bought 934,581 shares @ $10.7, valued at $10M
12/14/2022 4 Atlas Venture Opportunity Fund II, L.P. (10% Owner) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Bought 934,581 shares @ $10.7, valued at $10M
12/13/2022 4 Scalzo Richard William (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 31,000 shares @ $0
Sold 312 shares @ $10.87, valued at $3.4k
Granted 45,000 options to buy @ $10.72, valued at $482.4k
12/13/2022 4 McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 40,000 shares @ $0
Sold 472 shares @ $10.87, valued at $5.1k
Granted 63,000 options to buy @ $10.72, valued at $675.4k
12/13/2022 4 HIGH SUSANNA GATTI (COO) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 44,000 shares @ $0
Sold 751 shares @ $10.87, valued at $8.2k
Granted 69,000 options to buy @ $10.72, valued at $739.7k
12/13/2022 4 Farwell Wildon (Chief Medical Officer) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 36,000 shares @ $0
Sold 628 shares @ $10.87, valued at $6.8k
Granted 56,000 options to buy @ $10.72, valued at $600.3k
12/13/2022 4 Brumm Joshua T (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 144,000 shares @ $0
Sold 3,322 shares @ $10.87, valued at $36.1k
Granted 222,000 options to buy @ $10.72, valued at $2.4M
12/13/2022 4 Beskrovnaya Oxana (Chief Scientific Officer) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Granted 40,000 shares @ $0
Sold 680 shares @ $10.87, valued at $7.4k
Granted 63,000 options to buy @ $10.72, valued at $675.4k
10/11/2022 4 Brumm Joshua T (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Sold 14,200 shares @ $13.37, valued at $189.9k
Sold 195,800 shares @ $12.46, valued at $2.4M
Gifted 13,000 shares @ $0
Gifted 2,500 shares @ $0
Exercised 14,200 options to buy @ $1.03, valued at $14.6k
Exercised 195,800 options to buy @ $1.03, valued at $201.7k
09/21/2022 4 Scalzo Richard William (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Disposed/sold 840 shares @ $13.7, valued at $11.5k
09/21/2022 4 McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Disposed/sold 1,246 shares @ $13.7, valued at $17.1k
09/21/2022 4 HIGH SUSANNA GATTI (COO) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Disposed/sold 2,629 shares @ $13.7, valued at $36k
09/21/2022 4 Brumm Joshua T (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Disposed/sold 11,836 shares @ $13.7, valued at $162.2k
09/21/2022 4 Beskrovnaya Oxana (Chief Scientific Officer) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Disposed/sold 1,413 shares @ $13.7, valued at $19.4k
09/15/2022 4 Scalzo Richard William (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Disposed/sold 326 shares @ $14.05, valued at $4.6k
09/15/2022 4 Farwell Wildon (Chief Medical Officer) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Disposed/sold 658 shares @ $14.05, valued at $9.2k
09/15/2022 4 McNeill Jonathan (See Remarks) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Disposed/sold 494 shares @ $14.05, valued at $6.9k
09/15/2022 4 HIGH SUSANNA GATTI (COO) has filed a Form 4 on Dyne Therapeutics, Inc.
Txns: Disposed/sold 786 shares @ $14.05, valued at $11k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy